Medical Companies Partner on AI-Powered Footwear Service to Prevent Diabetic Amputations

Anderson Medical Supplies, AlexiGen, Defender, and Sensoria Health Inc. announced a collaborative partnership to deliver the Alternative to Amputation: Footwear as a Service (FAAS), a remote patient monitoring artificial intelligence platform designed to reduce amputation risk for diabetic foot ulcer patients. The integrated solution combines cutting-edge biologics with remote patient monitoring technology, advanced wound care solutions, clinically proven mechanical offloading footwear, and comprehensive clinical services to provide a more effective approach to diabetic foot ulcer management.

Diabetic foot ulcers affect approximately 15% of people with diabetes, with 6% requiring hospitalization due to infections or complications, and studies indicate that 14-24% of these patients will ultimately need amputations. This partnership addresses this critical healthcare challenge by bringing together Anderson Medical Supplies' patient monitoring clinical services, AlexiGen's skin graft products including their AmnioArmor dehydrated human amniotic membrane allograft, and Defender and Sensoria's Smart Boot with remote monitoring technology. The Defender smart boot, equipped with Sensoria Health's Sensoria Core and Smart Watch sensor technology, is currently being validated through an NIH R01 funded clinical study conducted by USC Keck School of Medicine and Baylor College of Medicine.

The Sensoria Remote Patient Monitoring mobile plus cloud software platform enables clinicians to track patients' adherence to treatment plans in near real-time, ensuring optimal performance of AlexiGen's skin substitutes and significantly increasing positive outcomes. The system demonstrates great promise for quantifying and monitoring patient adherence, activity, and treatment effectiveness for diabetic foot ulcers. By combining the best biologics and clinical services, the FAAS Platform represents a multidisciplinary effort that could fundamentally shift outcomes for those at risk of amputations.

The platform is available now, with the companies seeking early adopters among clinicians, podiatry, and wound care clinics interested in joining this holistic approach to treating diabetic foot ulcers. More information about the companies' technologies can be found at https://alexigen.com/, https://andersonmedsupplies.com/, and https://sensoriahealth.com/.